EOLS
Evolus Inc
NASDAQ: EOLS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$5.18
-1.71% today
Updated 2026-04-29
Market cap
$344.82M
P/E ratio
—
P/S ratio
1.16x
EPS (TTM)
$-0.80
Dividend yield
—
52W range
$4 – $12
Volume
1.1M
Evolus Inc (EOLS) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |